Edesa Biotech
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-1,118 |
Gross Profit | -51 | -45 | -45 | -1,164 |
EBITDA | -1,616 | -1,815 | -1,633 | -1,666 |
EBIT | -1,668 | -1,860 | -1,678 | -1,712 |
Net Income | -1,668 | -1,861 | -1,678 | -1,720 |
Net Change In Cash | 0 | 0 | 0 | -1,118 |
Free Cash Flow | -856 | -1,675 | -1,406 | -1,468 |
Cash | 2,040 | 2,799 | 4,267 | 5,361 |
Basic Shares | 3,221 | 3,192 | 3,128 | 3,027 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $ | $328 |
Gross Profit | -183 | -118 | -118 | 311 |
EBITDA | -9,222 | -17,429 | -13,223 | -6,343 |
EBIT | -9,222 | -17,548 | -13,342 | -6,400 |
Net Income | -8,374 | -17,548 | -13,343 | -6,364 |
Net Change In Cash | 0 | 0 | 328 | |
Free Cash Flow | -6,636 | -12,284 | -13,671 | -5,020 |
Cash | 5,361 | 7,090 | 7,839 | 7,213 |
Basic Shares | 2,858 | 2,096 | 1,725 | 1,229 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.52 |
2024-03-31 | -$0.58 |
2023-12-31 | -$0.54 |
2023-09-30 | -$0.60 |
